Clinical case report of severe pediatric exogenous intoxication by sodium valproate with fatal outcome

Authors

DOI:

https://doi.org/10.33448/rsd-v14i11.49980

Keywords:

Sodium Valproate, Intoxication, Pediatrics.

Abstract

The general objective that guided this study was formulated as follows: to present a case report on sodium valproate intoxication in pediatrics. Accordingly, the specific objectives were defined in three topics: (1) to understand the patient’s clinical evolution related to this type of intoxication, from admission to the end of treatment in this institution; (2) to analyze the clinical complications resulting from this condition; and (3) to analyze the treatments proposed in the literature for intoxication caused by this drug. In general, this medication is classified as an anticonvulsant, used in cases of epilepsy and bipolar disorder, and sodium valproate is widely associated with intoxications, whether intentional or unintentional. Its main adverse effects include central nervous system depression, hepatotoxicity, electrolyte disturbances, and cardiac rhythm abnormalities, and it is rapidly absorbed through the gastrointestinal tract. The present case report addressed the patient A.R.S., aged 4 years and 3 months, referred from an urgent care unit on January 29, 2025, with a clinical presentation of exogenous intoxication by VPA (500 mg per tablet, ingestion of 49 tablets) and an unknown amount of amitriptyline 50 mg. The patient was admitted to the ICU of HUMAP in critical condition and, despite all implemented interventions, progressed to death on February 6, 2025, as a consequence of the large quantity of VPA ingested. The study revealed a lack of standardized protocols in the literature to guide the management of VPA intoxications and highlights the importance of such protocols to promote a more systematic approach in the care of these cases.

References

Barros, A. R. (2021). Ácido valpróico: aspectos toxicológicos e forenses. Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal.

Davutoglu, V., Neyal, M. & Altunbas, G. (2017). Ácido valpróico como causa de episódios transitórios de bloqueio da condução atrioventricular. J Atr Fibrillation. 9 (5):1520.

Doré, M., San Juan, A. E., Frenette, A. J. & Williamson, D. (2017). Importância clínica do monitoramento da concentração de ácido valpróico livre em pacientes com hipoalbuminemia. Farmacoterapia. 37 (8):900-7.

Ferrey, A. E., Geulayov, G., Casey, D., Wells, C., Fuller, A., Bankhead, C., Ness., J., Clements, C., Gunnell, D., Kapur, N. & Hawton, K. (2018) Toxicidade relativa de estabilizadores de humor e antipsicóticos: letalidade e toxicidade fatal associadas à autointoxicação. BMC Psychiatry. 18 (1):399.

Ghannoum, M., Laliberté, M., Nolin, T. D., MacTier, R., Lavergne, V., Hoffman, R. S., Gosselin, S., Grupo de Trabalho EXTRIP. (2015). Tratamento extracorpóreo para intoxicação por ácido valproico: revisão sistemática e recomendações do grupo de trabalho EXTRIP. Clin Toxicol (Filadélfia).

Ghodke-Puranik, Y., Thorn, C. F., Lamba, J. K., Leeder, J. S., Song, W., Birnbaum, A. K., Altman, R. B. & Klein, T. E. (2013). Valproic acid pathway. Pharmacogenetics and Genomics. 23(4), 236-41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696515/[3]

Liu, R., Xiao, L., Hu, Y., Yan, Q. & Liu, X. (2024). Estratégias de resgate para intoxicação por overdose de ácido valpróico: Série de casos e revisão de literatura. Clin Case Rep. 12 (1):e8367.

LiverTox. (2020). Informações clínicas e de pesquisa sobre lesão hepática induzida por medicamentos. Instituto Nacional de Diabetes e Doenças Digestivas e Renais; Bethesda (MD).

National Center for Biotechnology Information (2025). PubChem Compound Summary for CID 3121, Valproic Acid. Retrieved November 15, 2025 from https://pubchem.ncbi.nlm.nih.gov/compound/Valproic-Acid.

Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [free ebook]. Santa Maria. Editora da UFSM.

Rahman, M. & Nguyen, H. (2021). Valproic Acid. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://ncbi.nlm.nih.gov/books/NBK559112.

Rupasinghe, J. & Jasinarachchi, M. (2011). Encefalopatia progressiva com edema cerebral e infartos associados à overdose de valproato e diazepam. J Clin Neurosci. 18 (5):710-1.

Schumacher, J. D. & Guo, G. L. (2015). Revisão mecanística da esteato-hepatite induzida por medicamentos. Toxicol Appl Pharmacol. 289 (1):40-7.

Shadnia, S., Amiri, H., Hassanian-Moghaddam, H., Rezai, M., Vasei, Z., Ghodrati, N. & Zamani, N. (2015). Resultados favoráveis após manejo conservador de 316 pacientes intoxicados por valproato. J Res Med Sci. 20 (7):656-61.

Shnayder, N. A. et al. (2023). Efeitos terapêuticos e tóxicos dos metabólitos do ácido valpróico. National Library of Medicine.

Smits, J. E. M. P., Wallenburg, E., van Spanje, A., van Luin, M. & Marijnissen. R. M. (2017). Intoxicação por valproato em um paciente com níveis de valproato no sangue dentro da faixa terapêutica. J Clin Psiquiatria. 78 (4):e413-e414.

Toassi, R. F. C. & Petry, P. C. (2021). Metodologia científica aplicada à área de saúde. Editora da UFRGS.

Yin, R. K. (2015). O estudo de caso. Editora Bookman.

Published

2025-11-21

Issue

Section

Health Sciences

How to Cite

Clinical case report of severe pediatric exogenous intoxication by sodium valproate with fatal outcome. Research, Society and Development, [S. l.], v. 14, n. 11, p. e178141149980, 2025. DOI: 10.33448/rsd-v14i11.49980. Disponível em: https://www.rsdjournal.org/rsd/article/view/49980. Acesso em: 5 dec. 2025.